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InteractionIrreversible accumulation of protein aggregates represents an important problem both in vivo and in vitro. The
aggregation of proteins is of critical importance in a wide variety of biomedical situations, ranging from
diseases (such as Alzheimer's and Parkinson's diseases) to the production (e.g. inclusion bodies), stability,
storage and delivery of protein drugs. β-Cyclodextrin (β-CD) is a circular heptasaccharide characterized by a
hydrophilic exterior and a hydrophobic interior ring structure. In this research, we studied the effects of a
chemically modiﬁed β-CD (BCD07056), on the aggregating and refolding properties of BlaPChBD, a hybrid
protein obtained by inserting the chitin binding domain of the human macrophage chitotriosidase into the
class A β-lactamase BlaP from Bacillus licheniformis 749/I during its thermal denaturation. The results show
that BCD07056 strongly increases the refolding yield of BlaPChBD after thermal denaturation and constitutes
an excellent additive to stabilize the protein over time at room temperature. Our data suggest that BCD07056
acts early in the denaturation process by preventing the formation of an intermediate which leads to an
aggregated state. Finally, the role of β-CD derivatives on the stability of proteins is discussed.human macrophage chitotrio-
in; PEG, polyethylene glycol;
-cyclodextrin; TM, temperature
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Protein aggregation is an important phenomenon in biotechno-
logical processes as well as in human diseases [1,2]. In many cases,
aggregation occurs when proteins, under particular conditions, fail
to fold correctly or to remain correctly folded. This is a common issue
encountered both in vivo and in vitro. In vivo, protein aggregation
can result in a wide range of diseases, including amyloidoses (i.e.
Alzheimer's and Parkinson's diseases, and spongiform encephalopa-
thy), which are associated with the deposition of proteins into highly
structured aggregates into a variety of tissues.
Protein aggregation results from many causes such as prolonged
thermal treatments and incorrect folding during protein expression,
puriﬁcation, formulation, transportation, or storage. A growing num-
ber of peptides and protein are being used in therapy, the applicationof many of them is however hindered by unfavorable solubility,
instability or aggregation [3]. Hence, the ability to prevent or reverse
protein aggregation is vital to the production and formulation of
therapeutic proteins.
Many attempts have been undertaken to overcome in vitro protein
aggregation by using a variety of cosolutes such as L-arginine [4–7],
polyethylene glycol (PEG) [8,9] and cyclodextrins [3,10]. Cyclodextrins
are circular oligosaccharides composed of α-(1,4) linked α-D-glucosyl
units. The salient characteristic of a cyclodextrin molecule is the pres-
ence of a central “cavity” or “hole” which provides an excellent resting
site for hydrophobic molecules of appropriate dimensions [1,11]. The
α-, β- and γ-cyclodextrins consist of six, seven and eight glucosyl units,
respectively. β-cyclodextrins (β-CD), which represent the most abun-
dant class, have a rather limited solubility in water (about 18 g/L) [12]
and various derivatives have been synthesized to improve it [1,13].
Studies on cyclodextrins have essentially focused on their ability
to prevent aggregation during the renaturation step of proteins
expressed as inclusion bodies in their hosts. In a typical experiment,
puriﬁed inclusion bodies are solubilized in highly concentrated
solutions of chaotropic agents (e.g. urea, guanidinium chloride), and
then the denatured proteins are refolded by diluting the denaturant
[14]. The yield of refolding is often limited by protein aggregation
[4,14,15], and can be increased by adding β-CD in the refolding buffer
1147M. Vandevenne et al. / Biochimica et Biophysica Acta 1814 (2011) 1146–1153as shown for bovine carbonic anhydrase [1], α-amylase [16,17],
aminoacylase [18], human growth hormone [19] and insulin [20].
In a recent report, we have described the insertion of the chitin
bindingdomain (ChBD)of thehumanmacrophage chitotriosidase into a
solvent-exposed loop of a class A β-lactamase (BlaP) produced by
Bacillus licheniformis 749/I[21,22]. The resulting hybrid protein,
referred to as BlaPChBD, was constructed in order to study the
structural and functional reciprocal effects of an insertion on the
scaffold protein and a heterologous structured protein fragment.
This hybrid protein behaves as a soluble protein and conserves both
the chitin binding property and β-lactamase activity of the parental
proteins. Compared to the parental β-lactamase, the thermal
unfolding of the hybrid protein is not cooperative and involves the
formation of stable intermediate species which has the tendency to
aggregate [21].
In the present study, we have investigated the effects of a chemically
modiﬁed β-CD, monopropanediamino-β-cyclodextrin (called
BCD07056), on the inactivation time course of BlaPChBD at room
temperature and on its thermal unfolding, using a variety of techniques
including ﬂuorescence, UV-absorbance, far UV CD and mass spectrom-
etry. The results of this study show that the addition of BCD07056
enhances the life time of the protein at room temperature, restores a
cooperative thermal unfolding, allows the reversibility of the thermal
denaturation and prevents protein aggregation.
2. Materials and methods
2.1. Cyclodextrin
BCD07056 was produced and kindly provided by Biocydex
(France). This modiﬁed β-cyclodextrin is also known as 6-(3-
aminopropylamino)-6-deoxycyclomaltoheptaose and contains one
modiﬁcation per glucose ring. Different cyclodextrin concentrations
(1 mM, 10 mM and 100 mM) have been used in thermal denatura-
tion experiments of BlaPChBD. 10 mM was shown to be the optimal
cyclodextrin concentration, above that value, increasing cyclodextrin
concentration did not result in an increase of the protein stability. This
concentration was thus used in all our experiments.
2.2. Expression and puriﬁcation of the chimeric protein BlaPChBD
The experimental procedures have been described [21].
2.3. Enzymatic activity assays
The β-lactamase activity of puriﬁed proteins was measured with
nitroceﬁn (initial rate) and cephalothin (kinetic parameters determi-
nation) as substrates in 50 mM sodium phosphate, 150 mM NaCl, pH
7.5 at 25 °C. Speciﬁc activities, kcat and KM values of the puriﬁed
enzymes were determined as described by Matagne at al. [23].
2.4. Fluorescence studies
Fluorescence spectra of proteins were recorded with a SML-
AMINCO Model 8100 spectroﬂuorimeter (Spectronic Instruments) in
a 1 cm optical pathlength quartz cuvette in 50 mM sodium phosphate
buffer, 150 mM NaCl, pH 7.5 with or without 10 mM BCD07056 with
a protein concentration of 2,6 μM. The excitation wavelength was
280 nm. The ﬂuorescence spectra were recorded from 300 to 400 nm
and corrected for the ﬂuorescence of buffered solutions.
For ﬂuorescence spectra of aromatic amino acids solutions, the
excitation wavelengths were 280 nm, 274 nm and 257 nm to speciﬁ-
cally target Trp, Tyr and Phe, respectively. Their ﬂuorescence spectra
were recorded from 300 to 400 nm for Trp, from 284 to 384 nm for Tyr
and from274 to 374 for Phe. The amino acid concentrationwas 100 μM.Heat-induced transitions were monitored by measuring the
intrinsic ﬂuorescence of the protein solution. The temperature was
increased from 25 °C to 90 °C at a rate of 0.5 °C/min using a
programmed Lauda Ecoline RE306 water bath. Temperature in the
cell was checked using a thermometer. The used excitation and
emission wavelengths were 280 and 337 nm respectively. Data
were normalized using the pre- and post-transition baseline slopes
as described [24,25]. The buffer composition as well as protein
concentrations were exactly the same as described for ﬂuorescence
spectra.
Whenheat-inducedunfoldingwasmonitored in thepresenceofANS,
emission was recorded at 475 nm with excitation at 350 nm. Protein
(2.4 mM) was incubated in the presence of 345 μM ANS (εANS(350 nm)
4950 M−1 cm−1). Data were corrected for the background ﬂuorescence
of the solution in the absence of protein (buffer+ANS). The temperature
was increased from25 °C to 90 °C at 1 °C/min, and datawere collected as
described above.
2.5. Circular dichroism
Heat-induced unfolding transitions were monitored by far-UV CD
were recorded with a Jasco J-810 spectropolarimeter, equipped with a
Peltier holder at 222 nm. Temperature in the 0.1-cm pathlength cell
was checked using a thermocouple and corrected. Experiment
conditions were the same as indicated above and the temperature
was increased from 25 °C to 97 °C at a rate of 0.5 °C/min using a
protein concentration of about 2.6 μM in 50 mM phosphate buffer,
150 mM NaCl, pH 7.5. Data were acquired every 0.2 °C, with a four
second integration time and a 2 nm bandwidth. Data were normalized
using the pre- and post-transition baseline slopes as described [25].
2.6. Kr determination
Binding assays were conducted as follows: various concentrations
of the chimeric protein (25 nM to 3 μM) were incubated in the
presence of 10 mg of chitin in ﬁnal volume of 500 μl of 50 mM sodium
phosphate buffer, 150 mM NaCl, pH 7.5 at 22 °C with continual
mixing. The mixtures were centrifuged at 4 °C for 15 min at
13,000 rpm and the supernatant containing the free protein was
collected. The free protein concentration was determined using the
reporter β-lactamase activity. The amount of bound protein was
calculated as the difference between the initial protein concentration
and the free protein concentration after binding. The relative
equilibrium association constant (Kr) was determined by the method
described by Gilkes et al. [26] using the following equation:
B½  = N0½ Ka F½ 
1 + aKa F½ 
Where [B] is the concentration of bound ligand (moles. g chitin−1),
[F] the concentration of free ligand (molar), [N0] the concentration of
binding site in the absence of ligand, a the number of lattice units
occupied by a single ligandmolecule and Ka the equilibrium association
constant (L mol−1). The Ka value cannot be isolated from this equation
but the relative equilibrium association constant, Kr (L g chitin−1) is
deﬁned as:
Kr = N0½ Ka
2.7. Light scattering
The scattering analysis of protein aggregation was performed at
25 °C on an Uvikon XS spectrophotometer (Bio-Tek Instruments). The
apparent absorbance obtained was measured at 490 nm in a quartz
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Excess quantities of Phe, Trp or Tyr (Sigma) were added to 1 mL
Eppendorf tubes containing various concentrations of BCD07056
(BioCydex, France) at a neutral pH. The tubes were shaken until equi-
librium was reached (24 h). Thereafter, the solutions were ﬁltered
through 0.45 μm PVDF ﬁlter and the concentration of either Phe, Trp or
Tyr was spectrophotometrically determined using a Beckman Coulter™
(DU® 530) spectrophotometer at either 257, 280 or 274 nm respec-
tively. For each spectrophotometric determination a solution corre-
sponding to the same concentration of BCD07056 was used as a blank.
The experiments were carried out in duplicate at least three times
independently and an average value is presented.
2.9. Mass spectrometry
ESI-TOF mass spectrometry experiments were realized in 20 mM
acetonitril pH 7.4. The protein and β-cyclodextrin concentrations
were 5 μM and 10 μM, respectively.
3. Results
3.1. Conservation of the biological activities of BlaPChBD in the presence
of BCD07056
The effects of BCD07056 on both the β-lactamase activity and the
chitin binding property of BlaPChBD were investigated. The kinetic
parameters of the chimeric protein were measured in the presence or
in the absence of BCD07056 (10 mM) using cephalotin as substrate
(Table 1). The data suggest that the presence of BCD07056 slightly
increases the enzymatic activity, the kcat/KM value is increased by
three fold, mostly due to a two fold decreased of the KM value. To
analyze the effect of BCD07056 on the functionality of the inserted
ChBD, we determined the relative equilibrium association constant
(Kr) between BlaPChBD and chitin using the method described
by Gilkes et al. [26]. The calculated Kr values in the absence and in
the presence of BCD07056 are 5.4±0.5 L g−1 and 5.6±0.6 L g−1,
respectively. These results indicate that no alteration of the chitin
binding property of the chimeric protein is observed in the presence
of BCD07056.
3.2. Ability of BCD07056 to stabilize BlaPChBD during its storage at room
temperature
To investigate a possible stabilization effect of BCD07056 during
the storage of BlaPChBD, samples of the protein (320 nM) were in-
cubated in the presence and in the absence of 10 mM BCD07056, at
24 °C for three weeks. Every week, the initial rate of nitroceﬁn
hydrolysis was measured and normalized to the value obtained at
time 0 (Fig. 1). After three weeks, the hybrid β-lactamase conserved
73% of its initial enzymatic activity when incubated in the presence
of BCD07056, whereas when the enzyme was incubated for the same
period of time without the molecule, substrate hydrolysis was barely
detectable. These results show that BCD07056 is able to limit sig-
niﬁcantly the inactivation of the protein during is storage at room
temperature.Table 1
Kinetic parameters of BlaPChBD in the presence and in the absence of BCD07056.
Cephalotin was used as substrate in this experiment as substrate. The β-CD
concentration was 10 mM.
KM (μM) kcat (s−1) kcat/KM (μM−1 s−1)
−BCD07056 77±1 75±5 0.9±0.3
+ BCD07056 35±2 98±5 2.8±0.5Addition of BCD07056 to the partial inactivated enzyme (i.e.
enzyme incubated for 2 weeks at 24 °C) did not lead to any increase of
the enzymatic activity (data not shown) suggesting that BCD07056
can limit enzyme inactivation but cannot reverse it.3.3. Effects of BCD07056 on the thermal stability of BlaPChBD
Previously, we have reported that the thermal denaturation of
BlaPChBD is a non-cooperative process involving the formation of an
intermediate species between the native (N) and the unfolded (U)
states. Moreover, the thermal unfolding of BlaPChBD is only partially
reversible and involves aggregation [21].
The effects of BCD07056 on the thermal denaturation behaviour
of the protein were investigated by ﬂuorescence and far UV CD spec-
troscopies (Fig. 2). The transition curves monitored by intrinsic
ﬂuorescence exhibit an apparent single transition both in the absence
and in the presence of BCD07056, with apparent mid-transition (TM)
temperatures of 53.1±0.1 °C and 56.9±0.5 °C, respectively (Fig. 2(b)).
The weak increase of the TM value in the presence of BCD07056 indi-
cates that thismolecule has amoderate effect on the thermal stability of
BlaPChBD.
The data obtained by far UV CD show that the denaturation of
BlaPChBD in the presence of BCD07056 also follows an apparent single
transition (TM 57.1±0.8 °C). The normalized data obtained by ﬂuores-
cence (tertiary structures) and far UV CD (secondary structures) in the
presence of themodiﬁed β-CD are virtually superimposable, suggesting
that thermal unfolding of the chimeric protein follows a two state
transition without populating any detectable intermediate species
between N and U. This observation differs from that in the absence of
BCD07056; in this case, the curve obtained exhibits two transitions
(Fig. 2(a)) with apparent TM values of 53.3±0.7 °C and 67.6±0.3 °C.
To investigate the reversibility of the thermal unfolding of BlaPChBD
in the presence or in the absence of BCD07056, ﬂuorescence spectra
before and after a complete cycle of thermal denaturation/renaturation
weremonitored (Fig. 3). In the absence of BCD07056, only about 50% of
the spectroscopic signal is recovered after a complete denaturation/
renaturation cycle. In the presence of BCD07056, the ﬂuorescence of the
refolded state is very similar to that of the native state indicating that
thermal denaturation is reversible in the presence of the molecule.
These results are further supported by the enzymatic activity measure-
ments. The yields of recovered β-lactamase activity in the absence or inTime (weeks)
0,0 0,5 1,0 1,5 2,0 2,5 3,0 3,5
0
Fig. 1. Evolution of the enzymatic activity of BlaPChBD (320 nM) incubated at 24 °C in
function of time, in the presence (●) or in the absence (○) of 10 mM BCD07056.
Nitroceﬁn (100 μM) hydrolysis was measured in 50 mM phosphate buffer, 150 mM
NaCl, pH 7.5 in the presence of 0.64 nM BlaPChBD.
Temperature (°C)Temperature (°C)























Fig. 2. Thermal unfolding transitions of the BlaPChBD were monitored by far UV CD (a) and intrinsic ﬂuorescence (b), in the absence (○) and in the presence (●) of 10 mM
BCD07056. This experiment was carried out in a 50 mM phosphate buffer, 150 mM NaCl, pH 7.5. The protein concentration was 2.6 μM. For ﬂuorescence measurements, the
excitation and emission wavelengths were 280 nm and 337 nm respectively. For far UV CD measurements, the transitions were monitored at 222 nm.
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Fig. 3. Intrinsic ﬂuorescence spectra of the chimeric protein. Spectra of the native (solid
lines), unfolded (dotted lines) and refolded (dashed lines) stateswere recorded in 50 mM
sodium phosphate buffer, pH 7.5 in the absence (a) or in the presence (b) of 10 mM
BCD07056. Protein concentration was 2,6 μM. The excitation wavelength was 280 nm.
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(data not shown).
Kr determinations were also performed after renaturation of the
protein. Without BCD07056, only 48% of the Kr value was restored. In
contrast, the presence of BC07056 allows the complete recovery of
this value.
Next, we have studied the aggregation behaviour of the chimeric
protein after one cycle of thermal denaturation/renaturation by light
scattering at 490 nm1. A strong increase in scattering is measured with
a BlaPChBD sample heated to 80 °C and cooled at room temperature in
the absence of BCD07056 (Fig. 4(a)). In contrast, no signiﬁcant increase
in turbidity is detected when the protein denaturation/renaturation
cycle is performed in the presence of 10 mMBCD07056, suggesting that
this molecule prevents BlaPChBD aggregation.
To analyze in more detail the aggregation phenomenon during
the thermal unfolding of BlaPChBD in the absence and in the presence
of BCD07056, the protein was heated at a rate of 0.5 °C/min and the
absorbance at 490 nm of aliquots taken every 5 °C were measured.
The data presented in Fig. 4(b) suggest that aggregation observed in
the absence of BCD07056 occurs late in the transition (at ±75 °C),
namely 18 °C above the formation of the intermediate state observed
by far UV CD and ANS ﬂuorescence (Fig. 2). This observation suggests
that the aggregation does not involve directly the intermediate state
[21] but rather the unfolded state. But it has to be noticed that herein
we did not take into account any kinetic effects and that the inter-
mediate populated at lower temperature could exhibit low aggrega-
tion kinetic and be responsible of the observed aggregation.
Furthermore, when the addition of BCD07056 is performed at dif-
ferent temperatures during the thermal denaturation transition (Fig. 2),
namely at 52 °C (when the intermediate state is still populated in
minority), at 58 °C (when the intermediate state is highly populated) or
at 65 °C (when the denatured state begins to be mostly populated), the
molecule is not as efﬁcient as when it is added at 25 °C (Table 2). This
indicates that BCD07056 does not interact with the denatured state and
probably acts early in the denaturation process.3.4. Interaction between BlaPChBD and BCD07056
It has been proposed that the ability of cyclodextrins to bind to
the side chains of aromatic amino acids contributes to their anti-
aggregating effects on proteins [3,18,19]. The ﬂuorescence properties
of aromatic residues are sensitive to the microenvironment [27]. Thus
Table 2
Recovered enzymatic activity after a complete cycle of denaturation/renaturation. In
this experiment, BCD07056 has been added at different temperatures during the
thermal denaturation (10 mM ﬁnal concentration). The recovered activity was
determined by measuring the rate of nitroceﬁn hydrolysis expressed as μmole of
nitroceﬁn hydrolyzed/min/mg of protein.
Addition of
BCD07056
Initial rates of nitroceﬁn
hydrolysis (μmole/min/mg of




activity after a cycle
denaturation–renaturation
Non-denaturated 186±5 100%
25 °C 169±11 91±7%
52 °C 132±14 72±11%
58 °C 126±11 68±9%
65 °C 110±8 59±8%
75 °C 92±17 49 ±18%
No BCD07056 96±14 51±15%
Temperature (°C)

























































Fig. 4. Monitoring of protein aggregation by light scattering. (a) BlaPChBD (2.6 μM)
was heated to 80 °C at a rate of 0.5 °C/min in the absence and in the presence of 10 mM
BCD07056 in a 50 mM phosphate buffer, 150 mM NaCl, pH 7.5. The absorbance of the
solutions was measured at 490 nm after cooling down the samples. The control
represents a solution of non heated BlaPChBD with 10 mM BCD07056. (b) BlaPChBD
(2.6 μM) was heated to 80 °C at a rate of 0.5 °C/min in the absence (grey bars) and in
the presence (black bars) of BCD07056 in a 50 mM phosphate buffer, 150 mM NaCl,
pH 7.5. Every 5 °C, absorbance of the solutions was measured at 490 nm after cooling
down of the samples.
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Tryptophan (Trp), Phenylalanine (Phe) and Tyrosine (Tyr) as models.
The intrinsic ﬂuorescence spectra of the three aromatic amino acids in
the presence of increasing concentrations of BCD07056 are presented
in Fig. 5. The data show that the intrinsic ﬂuorescence of free Trp
increases after the addition of BCD07056. A blue shift (350 nm to
343 nm) of the maximum emission wavelength of Trp, characteristic
of decreased solvent access is observed. But this blue shift might also
be partly due to the fact that the Trp emission spectra become broader
in the presence of BCD07056. Kim and co-workers observed similar
results with the natural β-CD [18]. The intensity of the intrinsic
ﬂuorescence emission of Phe also increases with BCD07056 concen-
trations. In contrast, the ﬂuorescence of Tyr decreases with increasing
BCD07056 concentrations suggesting a ﬂuorescence quenching of
this residue by the β-cyclodextrin. These results indicate that theaddition of BCD07056 to solutions of free aromatic amino acids leads to
a micro-environmental change of the aromatic side-chains due to a
probable docking of the latter into the hydrophobic cavity of
BCD07056 molecules. These data are supported by the solubility
assays performed on the three aromatic residues (Fig. 6) which give
a crude measure of the interaction between the free aromatic resi-
dues and the cyclodextrin.The curves were obtained by plotting the
absorbance of the ﬁltered amino acid solutions at speciﬁcwavelengths
in function of BCD07056 concentrations. From these experiments, we
can conclude that BCD07056 increases the solubility of the three aro-
matic amino acids.
In order to detect any interaction between BCD07056 and the native
BlaPChBD, intrinsic ﬂuorescence spectra of the protein were recorded
in the presence of themolecule upon excitation at 295 nm, 274 nm and
257 nm to speciﬁcally target Trp, Tyr and Phe residues, respectively. The
results (not shown) demonstrated that addition of 10 mM BCD07056
did not affect the intrinsic ﬂuorescence of the protein solution what-
ever the excitation wavelength was. We also compared the intrinsic
ﬂuorescence spectra of the thermal denatured form of the protein in
the presence or in the absence of BlaPChBD, no change was observed
(not shown). This indicates that themicroenvironments of the aromatic
side-chains of the protein are not signiﬁcantly changed suggesting that
BCD07056 does not interact with either the native state or the dena-
tured state of the hybrid protein. This observation is in good agreement
with prediction of the solvent accessibility of aromatic amino acids
into BlaPChBD. The parental β-lactamase contains 3 Trp, 6 Tyr, 6 Phe
whereas ChBD contains 1 Trp, 2 Tyr, and 4 Phe. By using the crystal-
lographic 3D structure of BlaP (4BLM, RCSB PDB) [28], we were able to
make a prediction of the solvent accessibility of its aromatic residues
with the Swiss-Pdb viewer 3.7 program [29]. With the exception of
three poorly solvent exposed Tyr, all the other aromatic amino acids are
buried in the hydrophobic core of the protein. The 3D structure of ChBD
has not been solved yet.
The interaction between BCD07056 and the hybrid protein was
further studied by monitoring the ﬂuorescence of 1-Anilino-8-
naphthalenesulfonate (ANS). ANS is used widely as a conformational
probe of hydrophobic patches in proteins [30]. Results of ANS binding
experiments realized in the presence or in the absence of BCD07056
are compared in Fig. 7. As described in our previous work [21], in the
absence of the β-CD, the thermal denaturation of BlaPChBD was
accompanied by a substantial increase of ANS binding up to about
57 °C indicating that thermal alterations of the BlaPChBD tertiary
structure occurred with the formation of ANS-accessible hydrophobic
clusters at the surface of the intermediate species. On the contrary, no
binding of ANS is observedwhen the thermal denaturation is performed
in the presence of β-CD. These data indicate that the accessibility of
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protein and themolecule or amore cooperativebehaviour of the protein
during thermal denaturation.λ (nm)







































































Fig. 5. Intrinsic ﬂuorescence spectra of tryptophan (a), phenylalanine (b), and tyrosine
(c). Spectrawere recorded in50 mMsodiumphosphatebuffer, 150 mMNaCl, pH7.5 in the
absence (dotted lines), or in the presence of 1 mM (dashed lines) or 10 mM (solid lines)
BCD 07056. The excitation wavelength for Trp, Phe and Tyr solutions was respectively
295 nm, 257 nm and 274 nm. The used amino acid concentration was 100 μM.
BCD07056 (mg.L-1)






















Fig. 6. Solubility of phenylalanine (●), tyrosine (○) and tryptophan (□) in the presence
of increasing concentrations of BCD07056. These data represent the concentration of
each amino acid in solution in the presence of an increasing BCD07056 concentration.
They can be seen as a crude measure of the interaction between the aromatic residues
and the cyclodextrin.4. Discussion
Protein aggregation is considered as acting in competition with
the protein folding pathway. This concept was derived from the fact
that protein aggregation is a common property of polypeptide chains
and that the process often takes place from at least partially unfolded
state [31,32]. Generally, the native protein and aggregates can be
seen as originating from a common population of partially unfolded,
interconverting molecules which interact with either the solvent or
neighboring molecules. In other words, protein aggregation and
protein folding are two sides of the same coin, and it could be argued
that structural factors playing relevant roles in one process are also
involved in the other [31].
Theefﬁciencyof protein folding isdeterminedby the respective rates
of folding and aggregation [18,33,34]. To prevent protein aggregation,
various low-molecular-weight chemical additives have been success-
fully used [35–37]. Among them, cyclodextrins have shown to be
efﬁcient for the correct refolding of a number of proteins [1,3,16,19]. TheTemperature (°C)






















Fig. 7. Thermal unfolding of BlaPChBD monitored by ANS ﬂuorescence at 475 nm and
recorded in the presence (○) and in the absence (●) of 10 mM BCD07056. Protein
(2.4 mM) in 50 mM phosphate buffer (pH 7.5) was incubated in the presence of 345 μM
ANS (εANS=4950 M−1 cm−1). Data were corrected for the background ﬂuorescence of
the solution in the absence of protein (buffer+ANS). The excitation wavelength was
350 nm.
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size and the nature of the chemical modiﬁcations found on the ring of
the sugar molecules [1].
In this work, we investigated the effect of a chemically modiﬁed
β-CD (BCD07056) on the stability and aggregation behaviour of the
hybrid protein BlaPChBD. Until now, most studies performed in the
presence of cyclodextrins have focused on their anti-aggregating
effect during the refolding process of chemically denatured proteins.
Here, we speciﬁcally monitored the effects of a chemically modiﬁed
β-cyclodextrin on the thermal unfolding process of BlaPChBD and
enzyme inactivation during long storage at room temperature.
The results obtained by incubating BCD07056 with the chimeric
protein at 24 °C for three weeks indicated that the presence of
BCD07056 signiﬁcantly limits the inactivation of the protein. But if
BCD07056 is added after the inactivation of the chimeric protein, no
signiﬁcant recovery of enzyme activity is observed. This suggests
that BCD07056 can prevent the inactivation of BlaPChBD but cannot
reverse it. Thus, BCD07056 constitutes a suitable additive to maintain
protein stability during storage.
Many studies have reported interactions between cyclodextrins and
proteins via exposed aromatic residues [1,3,19]. It is reasonable to
assume that interactions between cyclodextrins and proteins are likely
to occur during protein denaturation, since it is during the unfolding
process thatmost of the buried hydrophobic residues of the polypeptide
become solvent-exposed [1]. Our results support this hypothesis since
our experiments do not allow the detection of direct interactions
between BCD07056 and the native form of BlaPChBD.
In a previous work, we reported that thermal denaturation of
BlaPChBD was accompanied by the formation of an intermediate
state (I) which exhibits ANS-accessible hydrophobic clusters. In the
present study,we show that aggregation begins to occur at 70 °C. At this
temperature, the mostly populated state is the unfolded state (U). This
suggests that U could be involved in the aggregation phenomenon
instead of (I) as we previously proposed [21] (although long aggrega-
tion kinetics could also occur involving species populated earlier
than U in the denaturation process). Thus, we propose that, in the
absence of BCD07056, the thermal denaturation pathway favors the
formation of the intermediate state (I) and then the unfolded state (U)
which tends to precipitate irreversibly and to form the aggregated
state (A) (Scheme 1). In the presence of BCD07056, the superposition
of the denaturation transitions monitored by intrinsic ﬂuorescence and
far UV CD indicates that the denaturation of secondary and tertiary
structures occurs simultaneously. This demonstrates that thermal
denaturation of BlaPChBD in the presence of the molecule occurs with-
out populating any stable intermediates. Moreover, in addition to
restore the cooperativity of the thermal denaturation of the hybrid
protein, the modiﬁed β-cyclodextrin also increases drastically its
reversibility by preventing protein aggregation. Indeed, in the presence
of the molecule, the yield of recovered enzymatic activity is 91±7%.
In the case of cyclodextrins, stabilization of proteins involves nec-
essarily an interaction between the macromolecule and the stabilizing
agent. In our study, the data suggest that no stabilizing interactionScheme 1. Proposed denaturation Process of BlaPChBD in the absence of BCD07056.
N denotes the native state; I and I′ the intermediate states, U and U′ the irreversibly and
reversibly unfolded states respectively and A denotes the aggregated state. In the
absence of BCD07056, the irreversible pathway leading to protein aggregation is
favored. In the presence of the molecule the reversible pathway is mostly populated by
the protein molecules.occurs between BCD07056 and either the native state (N), the
intermediate state (I) or the denatured state (U). Indeed, ﬂuorescence
spectra experiments suggest that no interaction occurs between the
molecule and either the native state (N). An interaction between
BCD07056 and the intermediate state (I) was also excluded because
this one is not formed in the presence of the β-CD. And ﬁnally, since the
addition of BCD07056 at 75 °C does not improve the reversibility of
the thermal denaturation, and that no change in the ﬂuorescence of
the denatured state recorded with or without the cyclodextrin was
observed, we excluded any interactions with the unfolded state (U/A).
Thus, we suggest that another intermediate species (I′) exists and is the
target of BCD07056. This species probably presents solvent exposed
aromatic amino acids which interact with the modiﬁed β-CD as soon
as it is formed. We assume that this species appears early in the dena-
turation process. ANS binding experiments support an interaction
between cyclodextrin and BlaPChBD during this denaturation pro-
cess. However, it has to be noticed that the loss of ANS binding in the
presence of themoleculemay alsobe explainedby themore cooperative
behaviour of the protein in its presence. In the later case no ANS inter-
action would be observed because the denaturation of the protein
would occur cooperatively without exposing hydrophobic patches able
to bind ANS.
5. Conclusions
In conclusion, we hypothesize that in the absence of themolecule,
the denaturation process of BlaPChBD is multi-state as shown in
Scheme 1. When BCD07056 is present, the denaturation process
is modiﬁed. When temperature begins to increase, the molecule
interacts with aromatic residues of the species I′ as soon as they are
solvent-exposed. This prevents the formation of the species I and
leads to a modiﬁed denatured state (U′) which does not aggregate.
Thus, BCD07056 could prevent exposure of hydrophobic clusters by
producing a sort of “protective entrapment” which modiﬁes the dena-
turation process and prevents aggregation of the protein. In summary,
we proposed that in the absence of BCD07056 the irreversible pathway
leading to protein aggregation is favored and that, in the presence of the
molecule, the reversible pathway is mostly populated by the protein
molecules.
An alternative hypothesis that could explain how BCD07056
stabilizes the hybrid protein would be that one or more non-detectable
soluble intermediate(s) are formed in the early stage of the thermal
denaturation process, these intermediates would exhibit low aggrega-
tion kinetics and would be the target of the modiﬁed cyclodextrin. The
binding of BCD07056 to these intermediates would stabilize them and
therefore prevent aggregation. In this alternative model the denatur-
ation process would follow a single pathway that would include these
aggregation-prone intermediates in the early stage.
Thus BCD07056 could be seen as a molecular chaperone which
prevents aggregation during thermal unfolding by limiting the number
of protein molecules engaged in the denaturation process that leads
to aggregation. The way this molecule acts could be by (a) stabilizing
the unfolded state preferentially over the intermediate state, (b) by
destabilizing the intermediate, or (c) a combination of both.
Finally, the ability of β-cyclodextrins to accommodate solvent-
exposed aromatic side chains into its cavity explains the wide range of
cyclodextrin effects on different proteins: protection against degrada-
tion (if points of attack by proteases are masked by steric hindrances
of cyclodextrins), alteration of biological function (if residues involved
in function are masked by cyclodextrin) [3] and aggregation suppres-
sion (if residues responsible for aggregation are solvent accessible in
the native or in a partially unfolded state of a protein). Thus the exact
effects of cyclodextrins on a given protein always depend on its speciﬁc
structure [3]. Consequently, these effects are difﬁcult topredict andhave
to be investigated in each particular case. Our results show that the
BCD07056 cyclodextrin derivative is a good additive to stabilize protein
1153M. Vandevenne et al. / Biochimica et Biophysica Acta 1814 (2011) 1146–1153without interfering with enzymatic and polysaccharide binding
activities.
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